C12N 5/0642
Granulocytes
Official title: {Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells}
C12N5/0642 (Granulocytes) appears on 99 US grants and 165 published applications in this corpus.
Search patents in C12N- Granted patents
- 99
- Published applications
- 165
- Assignees
- 123
- Inventors
- 372
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 4 |
| 2004 | 0 | 5 |
| 2005 | 0 | 4 |
| 2006 | 1 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 2 | 4 |
| 2010 | 1 | 4 |
| 2011 | 1 | 4 |
| 2012 | 1 | 4 |
| 2013 | 3 | 5 |
| 2014 | 6 | 4 |
| 2015 | 5 | 7 |
| 2016 | 3 | 5 |
| 2017 | 3 | 7 |
| 2018 | 1 | 6 |
| 2019 | 3 | 8 |
| 2020 | 1 | 9 |
| 2021 | 8 | 19 |
| 2022 | 3 | 7 |
| 2023 | 6 | 9 |
| 2024 | 7 | 22 |
| 2025 | 5 | 12 |
| 2026 | 5 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and composition for modulating immune response and immune homeostasis11 Aug 2026US 12,702,696 B2Massachusetts Institute of Technology
- End-to-end cell therapy bioprocessing device for continuous-flow enrichment, washing, and electrotransfection of target cells21 Jul 2026US 12,686,843 B2The Charles Stark Draper Laboratory, Inc.
- Neutrophil progenitors and related methods and uses9 Jun 2026US 12,650,428 B2Agency for Science, Technology and Research
- Compositions and methods for microglia replacement therapy28 Apr 2026US 12,612,599 B2Savanna Biotherapeutics, Inc.
- Superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery, and preparation method thereof10 Feb 2026US 12,544,452 B2Jiangsu University
- A modified cell and uses thereof17 Sep 2026US 2026/0272981 A1
- Generation of induced neutrophils with increased activation and transmigration capabilities10 Sep 2026US 2026/0265695 A1
- Method for regulating degree of cell differentiation30 Jul 2026US 2026/0218131 A1National University Corporation Chiba University
- Cancer-killing cells23 Jul 2026US 2026/0207663 A2LIfT BioSciences Ltd
- In vivo and ex vivo production of car-neutrophils and use thereof to treat and image cancer23 Jul 2026US 2026/0207776 A1Purdue Research Foundation
Most cited
By later US patents
- Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells210US 5,437,994 AThe Regents of the University of Michigan · 1995
- Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells159US 6,326,198 B1The Regents of the University of Michigan · 2001
- Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells151US 5,763,266 AThe Regents of the University of Michigan · 1998
- Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture146US 5,635,386 AThe Regents of the University of Michigan · 1997
- Methods for the ex vivo replication of human stem cells and/or expansion of human progenitor cells145US 5,646,043 AThe Regents of the University of Michigan · 1997